Endovascular management of inferior vena cava filter thrombotic occlusion

Branco, Bernardino C.; Espinoza, Eduardo; Labropoulos, Nicos; Zea-Vera, Rodrigo; Leon, Luis R.; Gamero, Maria; Montero-Baker, Miguel F.

dc.contributor.author	Branco, Bernardino C.
dc.contributor.author	Montero-Baker, Miguel F.
dc.contributor.author	Espinoza, Eduardo
dc.contributor.author	Gamero, Maria
dc.contributor.author	Zea-Vera, Rodrigo
dc.contributor.author	Labropoulos, Nicos
dc.contributor.author	Leon, Luis R.
dc.date.accessioned	2018-11-30T03:10:45Z
dc.date.available	2018-11-30T03:10:45Z
dc.date.issued	2018
dc.identifier.uri	https://hdl.handle.net/20.500.12866/4054
dc.description.abstract	Objective: Inferior vena cava occlusion is a potentially life-threatening complication related to caval filters. We present our experience with filter-induced inferior vena cava occlusion in order to assess the feasibility, safety, and effectiveness of endovascular management. Methods A retrospective review of all patients undergoing inferior vena cava filter placement over a 60-month study period was performed. From this cohort, a total of 10 cases of inferior vena cava occlusion after filter placement were identified. Demographics, clinical data, procedures, and outcomes were extracted. Patients were followed to the last clinic visit or until they died. Results One-hundred eighty filters were placed by our group practice during the study period. Of those, a total of 10 patients were identified. Overall, there were 7 males; the mean age was 57.1 years (25-78 years). The median time between inferior vena cava filter placement and filter occlusion was 105 days (range 5-4745 days). All patients were clinically symptomatic at the time of their presentation. Nine out of 10 patients were successfully managed endovascularly. Trellis™-8 thrombectomy was the most common endovascular strategy performed ( n = 9). Four patients had balloon angioplasty, two of those with stent placement for chronically occluded inferior vena cava/iliac veins. No thromboembolic complications developed during a median follow-up period of 233 days (range 4-1083 days). Conclusions Endovascular management of inferior vena cava occlusion is feasible, safe, and effective in decreasing thrombus burden in the presence of an inferior vena cava filter. Further studies evaluating long-term inferior vena cava patency and optimal surveillance regimen after endovascular management of filter-related inferior vena cava occlusion are warranted.	en_US
dc.language.iso	eng
dc.publisher	SAGE Publications
dc.relation.ispartofseries	Vascular
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject	Adult	en_US
dc.subject	Female	en_US
dc.subject	Humans	en_US
dc.subject	Male	en_US
dc.subject	Retrospective Studies	en_US
dc.subject	Aged	en_US
dc.subject	Middle Aged	en_US
dc.subject	management	en_US
dc.subject	Treatment Outcome	en_US
dc.subject	Time Factors	en_US
dc.subject	Angioplasty, Balloon	en_US
dc.subject	Arizona	en_US
dc.subject	endovascular	en_US
dc.subject	Endovascular Procedures	en_US
dc.subject	Feasibility Studies	en_US
dc.subject	filter thrombosis	en_US
dc.subject	Inferior vena cava	en_US
dc.subject	occlusion	en_US
dc.subject	outcomes	en_US
dc.subject	Phlebography	en_US
dc.subject	Prosthesis Implantation	en_US
dc.subject	Stents	en_US
dc.subject	Thrombectomy	en_US
dc.subject	Vena Cava Filters	en_US
dc.subject	Vena Cava, Inferior	en_US
dc.subject	Venous Thrombosis	en_US
dc.title	Endovascular management of inferior vena cava filter thrombotic occlusion	en_US
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	https://doi.org/10.1177/1708538118761398
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#3.02.04
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#3.02.11
dc.relation.issn	1708-539X